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ABSTRACT 	  
The transcriptional co-repressor p107 has previously been shown to determine the 
metabolic fate of differentiated mesenchymal stem cells and their progenitors in a cell 
autonomous manner. Importantly, our new data shows that p107 influences stem cell fate 
decisions by its nuclear re-localization that results in regulating the bioenergetic status of 
the cells during G0/G1 phase of the cell cycle. In particular, p107 depleted primary stem 
and progenitor cells at G0/G1 undergo profound metabolic alterations including anaerobic 
glycolysis and significantly increased respiration. Our results show that p107 KD and KO 
stem cells and progenitors have an inefficient malate-aspartate shuttle, which decreases 
the availability of NADH into the mitochondria. Additionally, we found significantly 
elevated levels of two enzymes that enhance glycolysis, LDHa and PDK2. The effect of 
bioenergetics on adipocyte lineage fates is evident from inhibition of anaerobic 
glycolysis, which prevented the brown-type differentiation potential of p107 KD stem 
cell lines.  
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LITERATURE REVIEW  
1. Adipose Tissue   
1.1 White Adipocytes 
White adipocytes are morphologically unilocular in nature, storing dietary energy as 
triacylglycerol (TAGs) in a single lipid droplet. They are found predominately in distinct 
white adipose tissue (WAT) depots including intra-abdominal (visceral) and 
subcutaneous (Gesta et al., 2007; Cinti, 2005). During a period of caloric need, the TAGs 
can be rapidly hydrolyzed by lipases, a process known as lipolysis, and the resulting fatty 
acids are transported to other tissues to be oxidized in the mitochondria to generate 
energy in the form of adenosine triphosphate (ATP) (Lafontan, 2008). WAT can also 
function as an endocrine organ, secreting a large number of cytokines, such as leptin, 
interleukin-6, and tumor necrosis factor α.These cytokines are commonly referred to as 
adipokines, and are able to affect whole-body energy homeostasis in both normal and 
disease states by influencing peripheral tissues such as the liver, skeletal muscle, and the 
hypothalamus in the brain (Kershaw and Flier, 2004).  
Under obesogenic stimuli, white adipocytes can increase in size (hypertrophy) and 
number (hyperplasia) leading to WAT expansion (Hirsch and Batchelor, 1976; Shepherd 
et al., 1993). The growth in cell number is a result of the increase in the number and 
subsequent differentiation of stem and progenitor cells that reside in the stromal vascular 
fraction (SVF) of WAT (Tang et al., 2003; Yu et al., 1997; Tang and Lane, 2012; 
MacDougald and Lane, 1995). Over time, the obesogenic state leads to a dramatic 
increase in size of individual white adipocytes causing WAT to fail as a storage vessel for 
lipids. Excess lipid that would normally be stored in WAT instead accumulates in various 
tissues such as the liver, pancreas and skeletal muscle. The overloading of free fatty acids 
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(FFAs) within these tissues reduces their metabolic efficiency leading to insulin 
resistance, β-cell dysfunction and liver steatosis  (Muoio and Newgard, 2006). 
Additionally, increased WAT results in the dysfunctional secretion of adipokines that 
have adverse effects on energy use and production (Hotamisligil et al., 1994; Mohamed-
Ali et al., 1997). Overall, this dysregulation causes chronic low-grade inflammation that 
leads to insulin resistance, dyslipidemia, type II diabetes and indirectly to cardiovascular 
disease (Rosen and Spiegelman, 2006).  
1.2 Brown Adipocytes  
In rodents, brown adipocytes that make up brown adipose tissue (BAT) are found 
in the interscapular, axillary, paravertebral, and perirenal regions (Park et al., 2014). 
More recently, Sanchez-Gurmaches and colleagues have also shown that brown 
adipocytes are also found residing within WAT depots of rodents (Sanchez-Gurmaches et 
al., 2014). Unlike white adipocytes, brown adipocytes are composed of several small 
lipid droplets. They are capable of synthesizing and storing TAGs but are functionally 
different than white adipocytes. Brown adipocytes are packed with mitochondria that 
contain uncoupling protein-1 (Ucp-1) in their inner membranes (Cinti, 2006). Normally, 
mitochondria metabolize substrates derived from glucose or fatty acids. These substrates 
generate reduced nicotinamide adenine dinucleotide (NADH) and reduced flavin adenine 
dinucleotide (FADH2), which supply the electrons that pass along the electron transport 
chain (ETC) through the inner membrane of the mitochondria. This process forms a 
proton gradient in the inter membrane space and the gradient is used to drive the 
production of ATP through ATP Synthase (Fernie et al., 2004). However, when activated 
by sympathetic nerves, Ucp-1 in brown adipocytes acts as a pore, providing an alternate 
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pathway for protons to leak back from the intermembrane space into the matrix of the 
mitochondria. The result is the release of energy as heat at the expense of ATP 
production in a process referred to as non-shivering thermogenesis (Cannon and 
Nedergaard, 2004) (Figure 1). Physiologically this is tightly controlled by the 
sympathetic nervous system and β3-adrenergic receptors (Bachman et al., 2002; Hansen 
and Kristiansen, 2006; Cannon and Nedergaard, 2004). For example, when a cold 
stimulus is sensed the nervous system transmits the message along preganglionic neurons 
to postganglionic neurons that densely innervate BAT. Postganglionic neurons release the 
catecholamine norepinephrine, which is able to activate the adrenergic receptors on target 
tissues such as the β3-adrenergic receptor found on the plasma membrane of brown 
adipocytes (Cannon and Nederggard, 2004). Once the receptor is triggered it causes a 
signaling cascade to increase Ucp-1 transcription as well as activate it, which generates 
internal heat. Uncoupling by Ucp-1 necessitates the increased utilization of glucose and 
fatty acids to maintain the proton gradient to produce sufficient ATP. In order to dissipate 
large amounts of energy in the form of heat, brown adipocytes also express a number of 
other pro-thermogenic genes aside from Ucp-1, such as peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (Pgc-1α). Thus brown adipocytes play an important 
role in heat production, blood TAG clearance and glucose disposal (Cannon and 
Nedergaard, 2004; Bartelt et al 2011). 	  
Brown adipocytes found in BAT are derived from the dermomyotome where 
skeletal muscle cells originate (Seale al., 2008). Lineage-tracing experiments using the 
muscle-specific myogenic factor 5 (Myf5) cre recombinase (Cre) Myf5-Cre system 
showed the common ancestry between skeletal muscle and brown adipocytes (Seale et 
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al., 2008; Lepper and Fan, 2010). In the lineage tracing experiments all cells that have 
ever expressed Myf5 at any time point during development are labelled by the expression 
of the reporter gene, green fluorescent protein. Using this system, Seale et al., showed 
that brown but not white fat cells arise from progenitor cells expressing Myf5, a gene 
previously thought to be expressed only in the myogenic lineage (Seale et al., 2008). 
Lepper et al. used another myogenic marker, paired box protein 7, and showed that the 
divergence of myoblasts and brown adipocyte progenitors occurred between embryonic 
days 9.5 and 11.5 in mice (Lepper and Fan, 2010). These findings helped explain why 
brown and not white adipocyte progenitors express myogenic genes (Timmons et al., 
2007). In addition, a Myf5+ lineage has also been attributed to a subset of brown 
adipocytes interspersed in WAT depots (Sanchez-Gurmaches et al., 2014).  	  
 
Figure 1. Diagram depicting the components of the ETC. See text for more detail.  
Figure 1
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1.3 Browning of WAT and Beige Adipocytes 
Another type of fat cell is the brown like adipocyte found in WAT, known as 
beige or brite (brown in white) (Harms and Seale, 2013; Enerbäck, 2009; Ishibashi and 
Seale, 2010). The emergence of beige adipocytes within WAT occurs in response to 
various environmental signals such as prolonged cold exposure, adrenergic signalling and 
exercise (Barbatelli et al., 2010; Cinti et al., 2002; Ma et al., 2012; Boström et al., 2012; 
Wu et al., 2014). Beige adipocytes are very similar to brown adipocytes expressing high 
levels of pro-thermogenic genes including Ucp-1, and are characterized by their 
multilocular lipid droplet morphology, and high mitochondria content (Harms and Seale, 
2013). However, other traits have been reported that differentiate brown and beige 
(brown-type) adipocytes in mice, including genetic variability in their occurrence, 
developmental origin, cell size, and elevated expression of certain transcripts (Waldén et 
al., 2012; Xue et al., 2007; Seale et al., 2008; Frontini and Cinti, 2010; Wu et al., 2012).  
The cellular origin of beige adipocytes has not been completely elucidated. Some 
studies have shown a distinct progenitor population that can give rise to beige adipocytes 
(Lee et al., 2012; Schulz et al., 2011; Wu et al., 2012). Beige adipocytes in the 
epididymal WAT arise through the differentiation of progenitors that express platelet-
derived growth factor receptor α, CD 34, and stem cell antigen 1 (Lee et al., 2012). Once 
differentiated these cells express a unique gene expression pattern different from both 
white and brown adipocytes (Wu et al., 2012). In 2013, Wang and colleagues used an 
inducible labelling system in which mature adipocytes were permanently labelled, and 
found that the majority of newly developed beige adipocytes were derived from de novo 
differentiation of progenitors in subcutaneous WAT (Wang et al., 2013). Alternatively, 
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some reports suggest that beige adipocytes are not independent cell types but result from 
transdifferentiation, which suggests that ‘browning’ and ‘whitening’ occurs through an 
interconversion of an existing mature adipocyte (Cinti, 2002; Perwitz et al., 2010; 
Rosenwald et al 2013). This idea emerged from the observation that cold exposure or 
treatment with a β3 agonist induced “browning” of retroperitoneal WAT independently 
of cellular proliferation (Himms-Hagen et al., 2000). Furthermore, cells with the 
morphological appearance of a transition state between white and brown-like have been 
identified (Vitali et al., 2012). Recently, Rosenwald et al. provided further evidence of 
transdifferentiation (Rosenwald et al., 2013). Using different genetic markers they 
demonstrated that beige adipocytes appear in response to an initial period of cold 
exposure, but subsequently take on the morphology and gene expression pattern of a 
typical white adipocyte after reintroduction to warm conditions. Moreover, many of these 
cells reactivated the thermogenic program when placed in the cold for a second time 
(Rosenwald et al., 2013). Taken together, de novo differentiation and transdifferentiation 
may coexist.	  
1.4 Characterization of Adipocyte Types in Humans 
Brown adipocytes are found, in the axillary, cervical, perirenal and periadrenal 
regions of neonatal humans (Hu et al., 2012; Lean et al., 1986). Until recently these were 
thought to disappear soon after birth.  However, the realization that humans possess 
active brown fat in adults was made with advanced positron emission tomography - 
computed tomography (PET/CT) technology (Cypess et al., 2009; Saito et al., 2009). 
PET/CT scans measuring fluorescently tagged glucose (18-fluorodeoxyglucose) uptake in 
cancer patients noted an increased uptake at the supraclavicular, spinal and suprarenal 
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regions that were not tumors but attributed to brown and/or beige adipocytes (Cypess et 
al., 2009; Saito et al., 2009). In 2009, Virtanen and colleagues were the first to show that 
the areas of cold-induced 18-fluorodeoxyglucose uptake in healthy adult subjects did in 
fact have the histologic features of brown fat and expressed mRNA and proteins that 
distinguish it from WAT (Virtanen et al., 2009).  
Recently, two papers have re-examined the nature of human brown fat, helping to 
classify Ucp-1 positive cells as either beige or brown adipocytes. Lidell et al. examined 
the interscapular BAT depot of human neonates and found that this depot expresses Ucp-
1, as well as zinc finger of the cerebellum1 (ZIC1), a selective marker for brown versus 
white adipocytes (Lidell et al., 2013). Importantly, ZIC1 has previously been shown to be 
absent in beige fat in vitro and in vivo, suggesting that neonates have only brown 
adipocytes (Waldén et al., 2012, Petrovic et al., 2010). However in adult humans, 
different fat depots of the neck revealed differences in the proportion of brown-type 
adipocytes that were attributed to the specific anatomical site from which they were 
obtained. Analysis of five different depots from the most superficial to the deepest depots 
(subcutaneous, subplatysmal, carotid sheath, longus colli and prevertebral) demonstrated 
that subcutaneous fat contained only white-like adipocyte, whereas beige-like adipocytes 
were located at the carotid sheath and brown adipocytes were located at the deepest site 
termed the musculus longus colli (Cypess et al., 2013). Interestingly, this morphological 
gradient was paralleled by a gradient of expression of Ucp-1 and other brown adipocyte 
specific genes (Cypess et al., 2013). Taken together, it appears that humans possess 
genuine classical brown adipocytes as neonates but as we progress into adults these 
regress somewhat and beige cells develop. 
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2. Metabolic benefits and Therapeutic Potential of Thermogenic Adipocytes  
An emerging idea is that promoting the development of more brown-type 
adipocytes could act as a ‘metabolic sink’ for glucose and TAGs, and lead to an 
improvement in systemic glucose and lipid homeostasis.  
From rodent studies, brown-type adipocytes are well established as being a 
powerful metabolic tissue with an immense capacity for blood TAG clearance and 
glucose disposal (Bartelt et al., 2011; Cannon and Nedergaard, 2004; Jakus et al., 2008). 
An early study surmised that it would take only 50 grams of activated BAT to sufficiently 
utilize 20% of an individual’s daily energy needs, thus revealing the potential of BAT to 
help combat obesity and its associated diseases (Rothwell and Stock, 1983). Moreover, 
using tracer molecules for both glucose and TAG, Bartelt et al. in 2011 demonstrated that 
in response to an oral glucose and fat load, BAT is capable of clearing 75% and 50% of 
the total glucose and triglycerides from circulation, respectively (Bartelt et al., 2011). 
Additionally, rodents with increased amounts of brown and/or beige adipocytes are leaner 
and more resistant to obesity and its complications (Bartelt et al., 2011; Cousin et al., 
1992; Dali-Youcef et al., 2007; Fitzgibbons et al., 2011; Scimè et al., 2005, 2010; Seale 
et al., 2007; Sellayah et al., 2011; Tseng et al., 2008). Alternatively, rodents with 
genetically deleted (KO) Ucp-1 exhibit impaired diet-induced thermogenesis (elevated 
metabolic rate following food ingestion) and are susceptible to becoming obese 
(Feldmann et al., 2009; Hamann et al., 1995, 1996; Lowell et al., 1993). Moreover, 
inhibition of beige adipocyte formation also promotes obesity in animals placed on a 
high-fat diet (Cohen et al., 2014).  
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 Importantly, in humans, the amount of brown-type fat correlates inversely with 
body mass index and percentage of body fat and directly with energy expenditure during 
rest (van Marken Lichtenbelt et al., 2009; Cypess et al., 2009). This suggests that natural 
variations in brown-type adipocyte function may contribute to fluctuations in energy 
metabolism and thus influence body weight in humans. Brown-type adipocyte activity 
has also been predicted to account for 2.7% to 5% of basal metabolic rate in humans, 
which could cumulatively promote more than 4 kg of WAT loss during the course of one 
year (Frühbeck et al., 2009; Virtanen et al., 2009).  
The benefits extend beyond weight loss, as investigations have revealed an 
inverse association of type II diabetes and activated brown fat (Ouellet et al., 2012; Lee, 
2010).  This is because brown-type adipocytes are very insulin sensitive, on par with 
skeletal muscle for glucose uptake (Orava et al., 2011). Recently, two independent 
research groups showed that recipient mice transplanted with human or mouse brown 
adipocytes, have increased lipid and glucose tolerance, enhanced insulin sensitivity, 
lower body weight, decreased fat mass and a complete reversal of insulin resistance when 
placed on a high fat diet (Nishio et al., 2012; Stanford et al., 2013). In humans, 
Matsushita and colleagues assessed various blood parameters using standard methods and 
reported that blood sugar levels, total cholesterol, and low-density lipoprotein cholesterol 
levels were significantly lower in cold activated BAT-positive patients versus patients 
without detectable BAT (Matsushita et al., 2014). Notably, using a hyperinsulinemic-
euglycemic clamp, men with significant amounts of activated BAT showed an increase in 
whole-body glucose disposal, plasma glucose oxidation and insulin sensitivity when 
exposed to prolonged mild cold temperatures (Chondronikola etl al. 2014). These results 
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support a physiologically significant role of brown-type adipocytes in glucose 
homeostasis and insulin sensitivity and thus hold promise in providing a therapeutic 
benefit for humans. 
3. Adipocyte Differentiation  
In general, adipocyte formation (adipogenesis) is divided into two stages; stem 
cell commitment, followed by the terminal differentiation process (Lefterova et al., 2009; 
Tang and Lane, 2012; MacDougald and Lane, 1995). In the first step, stem cells or their 
progenitor cells are committed to a white, brown or beige adipocyte lineage.  In the 
second stage, transcriptional activation of adipocyte specific genes occurs creating a 
specialized cell type. In vivo, stem cells and their progenitors receive external cues to 
differentiate in a quiescent (G0) or G1 phase of the cell cycle. In order to induce lineage 
commitment and adipogenesis in vitro, the stem cells mimic an in vivo state whereby they 
are required to be contact inhibited and in a non proliferating G0/G1 state (Valcourt et al., 
2012). 
Mesenchymal stem cells (MSCs) derived from the embryonic mesoderm are a 
class of stem cells with the capacity to differentiate into adipocytes (Covas et al., 2008; 
Lin et al., 2010). They are a part of a heterogeneous population of cells that make up the 
SVF of adipose tissue (Otto and Lane, 2005). They have a strong capacity for self-
renewal and may differentiate into various mesodermal cell types (Abumaree et al., 2012; 
Elabd et al., 2007, 2009; Liu et al., 2009; Rodriguez et al., 2005). However, much of our 
current understanding of adipogenesis is based on studies using cell lines that are lineage 
committed, such as 3T3-L1. Very little is known regarding the transcriptional signals that 
are involved during the commitment of MSCs to the white, brown or beige lineages. In 
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tissue culture, the non-committed C3H10T1/2 stem cell line provides a better model to 
study the process of adipocyte commitment and differentiation (Bowers et al., 2006; Tang 
et al., 2004; Tang and Lane, 2012; Tseng et al., 2008).  
Adipocyte differentiation in either white or brown fat is under the control of two 
key transcription factors, peroxisome proliferator-activated receptor γ (Pparγ) and the 
CCAAT/enhancer binding protein (C/ebp) family of transcription factors (Rosen and 
MacDougald, 2006). When these factors activate gene transcription they initiate a 
cascade of events leading to the development of a terminally differentiated adipocyte. 
Notably, in MSCs and C3H10T1/2 cells, the expression of both Pparγ and C/ebp induces 
only a white, not brown differentiation program (Rosen et al., 2000; Ahfeldt et al., 2012).  
3.1 Prdm16 a molecular switch promoting the differentiation of brown fat 
  It is well known that the expression of the co-regulator PRD1-BF-1-RIZ1 
homologous domain-containing protein 16 (Prdm16) is sufficient to drive the 
differentiation of stem cells and their uncommitted progenitors to the brown-type 
adipocyte cell fate (Kajimura et al., 2009, 2010; Seale et al., 2007, 2008). Overexpression 
of Prdm16 from both WAT or BAT derived SVF results in an increase in mitochondrial 
biogenesis, increased cellular respiration, and expression of brown-type adipocyte 
specific pro-thermogenic genes including Ucp-1, Pgc-1α, cell death-inducing DFFA-like 
effector a (Cidea) and ELOVL Fatty Acid Elongase 3 (Elovl3) (Seale et al., 2007, 2011). 
Notably, Prdm16 levels are higher in the more metabolically beneficial subcutaneous 
WAT depots containing more beige adipocytes compared to visceral depots (Kajimura et 
al., 2009; Seale et al., 2011). Intriguingly, a recent paper demonstrated that adipocyte-
specific deletion of Prdm16 in subcutaneous fat inhibits beige adipocyte function and 
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formation following cold exposure or β3 agonist treatment (Cohen et al., 2014). 
Subcutaneous depots from the Prdm16 mutant animals acquired negative properties of 
visceral fat, including decreased thermogenic and increased inflammatory gene 
expression when placed on a high-fat diet (Cohen et al., 2014). To date, at least one paper 
has shown Prdm16 master regulatory role in humans. Ahfeldt and co-authors showed that 
white adipose cells could be differentiated from MSCs and human adipose-derived SVF 
cells using Pparγ2. However, when combined with both C/ebpβ and Prdm16 these cells 
obtained a brown fat phenotype with abundant Ucp-1 expression (Ahfeldt et al., 2012).  
4. p107 and Adipogenesis  
p107 (Rbl1) is part of the retinoblastoma susceptibility gene (Rb) family that also 
includes the protein products Rb1 (pRb) and pRbl2 (p130). pRb was first identified as the 
tumor suppressor gene mutated in retinoblastoma, a rare childhood cancer (Lee et al., 
1987; Manning and Dyson, 2011). Subsequent research demonstrated that inactivation of 
pRb either directly by mutations, or indirectly through altered expression/activity of the 
protein’s pathway lead to a variety of human cancers (Burkhard and Sage, 2008). 
Conversely, p107 and p130 are rarely mutated or directly inactivated in human cancers, 
but have altered upstream regulation in response to Rb mutations (Burkhard and Sage, 
2008). The three Rb proteins are structurally similar, specifically in the pocket region, 
which is composed of two subdomains named A and B, separated by a ‘spacer’ region 
that is highly conserved among each of the proteins (Lee et al., 1987). Additionally, p107 
and p130 also contain a cyclin dependent kinase (cdk) inhibitor domain in the N-terminus 
that is not present in Rb (Ewen et al., 1991; Hannon et al., 1993; Li et al., 1993; Wirt and 
Sage, 2010). 
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p107 and its family members act as co transcriptional repressors unable to bind DNA 
directly but can interact with members of the E2F transcription factor family. 
Specifically, p107 interacts with E2F4 to repress the expression of genes that are 
predominately involved in the cell-cycle (Muller et al., 2001; Young et al., 2003; Attwoll 
et al., 2004). Upon hyperphosphorylation by Cyclin/Cdk complexes, p107 becomes 
inactivated such that binding to E2F4 is abrogated and gene transcription is de-repressed.  
The co transcriptional repression ability of this family of proteins is due to their 
association with a wide variety chromatin remodelling enzymes (Macaluso et al., 2006).	  
p107 has been shown to repress E2F-dependent transcription by recruiting type 1 and 2 
histone deacetylases (HDACs) and the histone methyltransferase suppressor of 
variegation 3-9 homolog 1 (SUV39H1) (Nicolas et al., 2003; Frolov and Dyson, 2004). 
Quantitative chromatin immunoprecipitation (qChIP) analyses demonstrated that p107 
recruit type 1 HDACs, resulting in removal of acetyl groups from histones H3 and H4, in 
a compacted structure of chromatin, which prevents transcription initiation (Ferreria et 
al., 2001; Rayman et al., 2002). 
p107, is highly regulated during adipocyte differentiation of the committed 
preadipocyte cell line 3T3-L1 by increasing dramatically after day 1 and disappearing by 
day 7 (Richon et al., 1997; Timchenko et al., 1999). The importance of p107 to 
adipogenesis is highlighted by the inhibition of adipocyte differentiation during its 
knockdown (KD) in 3T3-L1 cells (May et al., 2001). However, p107 KO murine 
embryonic fibroblasts (MEFs) can readily undergo adipocyte differentiation, with an 
increased potential over controls (Classon et al., 2000; Landsberg 2003). The findings of 
Scimè et al. suggested that p107 regulates stem cell commitment to determine adipocyte 
14	  	  
	   	  
lineage fate (Scimè et al., 2005). They found that p107 KO mice have a lean phenotype 
and display a pronounced level of beige and /or brown adipocytes with significant up 
regulation of Ucp-1 in WAT depots. Furthermore, these mice are resistant to weight gain 
when placed on a high fat diet and exhibited greater insulin tolerance than their wild type 
(Wt) littermate controls (Scimè et al., 2010). In 2014, De Sousa et al., revealed that 
suppression of p107 expression is necessary for the commitment of stem cells and their 
progenitors to the brown-type adipocyte lineage, providing a basis for the phenotypic 
character of p107 KO mice (De Sousa 2014, Scimè et al., 2005, 2010). Indeed, Prdm16 
was shown to down regulate both p107 protein and mRNA levels, suggesting that p107 is 
a downstream target of Prdm16 in the brown-type adipocyte lineage commitment 
pathway.  
5. Bioenergetics in Stem Cell Fate Decisions 
Adult stem cells are characterized by two essential functions: their self-renewal 
ability and their differentiation potential, which enable them to sustain the different 
tissues in the body throughout the lifespan of an organism (Eckfeldt et al., 2005). Much 
of the research on the mechanisms governing various stem cell fates (i.e. quiescence, self-
renewal or differentiation) has focused on how specific growth factors and extracellular 
matrix signals can elicit responses in stem cells. Interestingly, in recent years, there has 
been an emerging realization that, bioenergetics, which is the manner by which metabolic 
nutrient shuttling produces and utilizes energy, may also provide important signals that 
regulate stem cell properties (Figure 1). However, the biological significance and 
molecular mechanism underlying the metabolic regulation of stem cell fates remains 
largely elusive.  
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Figure 2. External cues define the metabolic character for how a stem cell will behave 
when activated. See text for more details. 
5.1 Aerobic Glycolysis  
In Mammalian cells, glycolysis is the metabolic pathway in which glucose is 
consumed and converted into pyruvate. Cells take up glucose through glucose 
transporters (Glut) where it is then metabolized to pyruvate through a series of ten 
enzymatic reactions. Pyruvate is then transported into the mitochondria as acetyl-CoA, 
through the action of pyruvate dehydrogenase (PDH), or as oxaloacetate, via pyruvate 
carboxylase where it is oxidized. The free energy released in the process of generating 
pyruvate is used to generate ATP and NADH, which can enter the mitochondria to be 
oxidized by the ETC.  
5.2 The Tricarboxylic Acid Cycle and Oxidative Phosphorylation 
The tricarboxylic acid (TCA) cycle, takes place inside the mitochondria where 
more NADH as well as FADH2 are produced, as well as vital carbon containing 
intermediates, such as oxaloacetate, acetyl-CoA and	  α-ketoglutarate. The NADH and 
FADH2 that are produced in the TCA cycle are oxidized through oxidative 
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phosphorylation (OXPHOS) by the mitochondrial ETC. The ETC is located in the 
mitochondrial inner membrane and result in a final reduction of molecular oxygen to 
water. The ETC is made up of 5 distinct complexes; complex I NADH dehydrogenase, 
Complex II succinate dehydrogenase, Complex III coenzyme Q-cytochrome c (Cyt c) 
reductase, Complex IV cytochrome oxidase and Complex V ATP synthase. Through a 
series of redox reactions, electrons pass along the ETC causing protons (H+) to be 
pumped from the matrix to the intermembrane space, creating a proton-motive force, 
whose energy is used by ATP synthase for the phosphorylation of ADP, generating ATP 
(Fernie et al., 2004). 
5.3 Anaerobic Glycolysis  
In the absence of oxygen, ATP cannot be formed via the mitochondria and thus 
pyruvate is alternatively converted into lactate, by lactate dehydrogenase (Ldh) (Figure 
3). Normally, cytosolic NADH can enter the mitochondria via metabolic shuttles. 
However, under anaerobic conditions, where the ETC is not functioning, cytosolic 
NADH is oxidized in the reaction of pyruvate to lactate. Importantly, glycolysis would 
cease to proceed by the decrease in the NAD+/NADH ratio if pyruvate was not converted 
into lactate, as its conversion provides the NAD+ required in the pathway. Under these 
anaerobic conditions, glycolysis releases a small amount of useable energy that can help 
sustain a cell even in a state of oxygen debt. Although glycolysis is inherently less 
efficient, producing a fraction of ATP compared to oxidative consumption of glucose, 
glycolysis does enable a fast rate of energy generation in response to acute changes in 
energy demand (Pfeiffer et al 2001). Additionally, under abundant supply of glucose, the 
percentage of ATP generated from glycolysis can surpass that produced by oxygen-
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dependent respiration (Guppy et al., 1993). As such, mitochondria may redirect away 
from oxidative ATP production thereby enabling the generation of carbon-containing 
intermediates, such as oxaloacetate, acetyl-CoA and	  α-ketoglutarate from the TCA cycle 
for biosynthetic purposes. In addition, generate the necessary glycolytic intermediates for 
the biosynthesis of new macromolecules via the pentose phosphate pathway (PPP) 
(Folmes et al., 2012). 
 
Figure 3. Diagram representing key enzymes in anaerobic glycolysis. See text for more 
details  
 
5.4 NADH Mitochondrial partitioning 
 NADH produced from glycolysis can subsequently be oxidized by the ETC chain 
and generate ATP, but it cannot enter the mitochondrion directly. The primary mode of 
transportation of NADH into the mitochondria is the malate-aspartate shuttle system 
(Figure 4). The primary enzyme in the malate-aspartate shuttle is malate dehydrogenase 
(Mdh). Mdh is present in two forms, cytosolic malate dehydrogenase (Mdh1) and 
Figure 3
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mitochondrial malate dehydrogenase (Mdh2). In the first reaction, Mdh1 catalyses the 
reaction of oxaloacetate and NADH to produce malate and NAD+. Malate is then 
imported from the cytosol into the mitochondrial matrix via the malate-α-ketoglutarate 
antiporter, which simultaneously exports α-ketoglutarate from the matrix into the cytosol. 
After malate reaches the mitochondrial matrix, it is converted into oxaloacetate by Mdh2, 
during which NAD+ is reduced to form NADH. Oxaloacetate, which cannot be 
transported into the cytosol, undergoes transamination by mitochondrial aspartate 
aminotransferase (Got2) with glutamate to make aspartate and α -ketoglutarate. Aspartate 
is returned to the cytosol by the second antiporter (the glutamate-aspartate antiporter), 
which imports glutamate from the cytosol as it exports aspartate from the matrix to the 
cytosol. Once in the cytosol, aspartate is converted back to oxaloacetate by cytosolic 
(Got1).  
 
Figure 4. Diagram representing the malate-aspartate shuttle. See text for more detail. 
Cytosol  Mitochondrial Matrix 
Malate Malate Oxaloacetate Oxaloacetate 
NADH NAD+ NAD+ NADH 
Mdh2 Mdh1 
Glutamate Glutamate 
Aspartate Aspartate 
α-ketoglutarate α-ketoglutarate 
Got1 Got2 
Glu-Asp 
antiporter 
Malate-αKG 
antiporter 
Figure 4
19	  	  
	   	  
5.5 β-oxidation of Fatty Acids  
Fatty acids primarily enter a cell via fatty acid protein transporters located on the 
cell surface (Lopaschuk et al., 2010). The membrane associated fatty acid transporters 
include fatty acid translocase, tissue specific fatty acid transport proteins (Fatp), and 
plasma membrane bound fatty acid binding protein (Fabp) (Su and Abumrad, 2009). The 
oxidation of fatty acids occurs primarily within the mitochondrion and produces energy 
through OXPHOS. Short-chain fatty acids can pass directly into the mitochondrial matrix 
and form acyl-CoA derivatives and can subsequently enter β-oxidation (Berg, 2007 6th 
Editon). Conversely, long-chain fatty acids and their CoA derivatives are incapable of 
crossing the inner mitochondrial membrane (but can cross the permeable outer 
membrane), so a membrane transport system is necessary. Once inside the cell, a CoA 
group is added to the long-chain fatty acid by fatty acid synthase (FAS), forming long 
chain acyl-CoA. The activated fatty acid is then joined covalently to carnitine at the 
cytoplasmic side of the mitochondrial membrane by the transferase enzyme carnitine 
palmitoyltransferase 1 (Cpt1) forming fatty acylcarnitine.  The conversion to 
acylcarnitine allows the fatty acid to be transported across the inner mitochondrial 
membrane via carnitine translocase (Cat), which exchanges long chain acylcarnitines for 
carnitine. A second transferase, carnitine palmitoyltransferase 2 (Cpt2), located on the 
inner mitochondrial membrane then converts the long chain acylcarnitine back to long 
chain acyl-CoA. The long chain acyl-CoA, now located within the mitochondrial matrix, 
is free to enter fatty acid β-oxidation (McGarry and Brown, 1997) (Figure 5). 
Fatty acid β-oxidation is a multi-step process by which fatty acids are broken 
down by in the mitochondrial matrix of a cell to produce energy. In short, this cyclic 
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degradative pathway allows acetyl-CoA to be cleaved from a long chain acyl-CoA 
molecule. The number of acetyl-CoA produced depends upon the carbon length of the 
fatty acid being oxidized. Additionally, during β oxidation NADH and FADH2 are 
formed (Vance and Vance, 2008).   
 
Figure 5. Diagram representing fatty acid transport into the mitochondria. See text for 
further details.  
6. Metabolic Regulation of Stem Cell Fates 
It is well known that different cell states require specific metabolic programs to 
support the unique demands underlying their specialized functions. Once thought to be a 
mere consequence of the state of a cell, it is now thought that metabolism plays an active 
role in dictating stem cell fates whether it be for remaining quiescent, proliferating or, 
differentiating (Ochocki and Simon, 2013). 
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6.1 Glycolysis and stem cell fates 
The notion that metabolic reprogramming might play role during stem cell fate 
decisions originated from cellular metabolism as an underling cause of the ability of 
cancer cells to proliferate uncontrollably. In particular, the generation of ATP through 
glycolysis, despite the presence of oxygen, a phenomenon known as the Warburg effect 
(Lunt and Vander Heiden, 2011). The most prevalent explanation for the Warburg effect 
in tumors suggests that it is a strategy to deal with the anabolic demands of proliferation 
since many of the metabolites for energy-producing pathways are rerouted to biosynthetic 
pathways to support macromolecular synthesis needed in cell division (Vander Heiden, 
2009; Lunt and Vander Heiden, 2011). Recent results suggest that there might be 
additional functions of glycolysis in the regulation of stem cell fate. For example, the 
induction of pluripotency is accompanied by the distinct changes in bioenergetics 
characterized by the conversion from an oxidative state in somatic cells to a glycolytic 
state in pluripotency (Folmes et al., 2011b; Zue et al., 2010; Yanes et al., 2011). Several 
adult stem cells also heavily rely on anaerobic glycolysis to maintain a quiescent state, 
and are more sensitive to oxidative stress. In hypoxic conditions, such as those found in 
the stem cell niche of hematopoetic stem cells (HSCs) and MSCs, the transcription factor 
hypoxia-inducible factor 1α (HIF-1α) promotes glycolysis as it induces the expression of 
pyruvate dehydrogenase kinases (PDKs) thus blocking mitochondrial respiration.  
6.2 Mitochondria and oxidative phosphorylation in stem cell fates  
 Mitochondrial activation and remodeling of bioenergetics systems are essential in 
supporting the differentiation processes (Folmes et al., 2011a). In general, cellular 
differentiation is characterized by fully developed and functional mitochondria that have 
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higher ATP production through better coupling of glycolysis and TCA cycle as well as 
increased capacity for antioxidant defense (Panopoulos et al., 2012; Folmes et al., 2011a; 
Armstrong et al., 2010; Prigione et al., 2011).	  	  
MSCs have the ability to reconfigure their metabolic network to accompany such 
fate specification; in which changes in glycolytic pathway and mitochondrial biogenesis 
are the most pronounced (Liu and Ma, 2014). During adipogenic differentiation of MSCs, 
there is an increase in mitochondrial biogenesis, respiration, mitochondrial membrane 
potential, and oxygen consumption, whereas reducing mitochondrial respiration by 
hypoxia or by inhibition of the ETC, suppresses adipogenic differentiation (Tormos et al., 
2011; Zhang et al., 2013).  
6.3 Alternative metabolic Pathways in stem cell fates 
Other metabolic manipulations can also affect stem cell fate decisions. For 
example, fatty acid oxidation (FAO) plays an important role in the maintenance of HSCs 
and the inhibition of the FAO pathway results in differentiation of HSC progenitors (Ito 
et al., 2012). Inhibition of the eicosanoid pathway, which maintains high levels of 
unsaturated fatty acids, preserves stem cell pluripotency, while addition of saturated 
metabolites to embryonic stem cell (ESC) media accelerates lineage specification (Yanes 
et al., 2011). This suggests that metabolic changes could not only be necessary for 
differentiation, but may also control it by regulating signaling pathways and gene 
expression directly via the metabolites they produce.  Recent evidence suggests that 
lactate has autocrine-, paracrine- and endocrine-like actions suggesting it may function as 
a signaling molecule termed ‘lactoromone’, rather than a glycolytic waste product 
(Brooks, 2009). Specifically, research has shown that lactate can control gene expression 
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in several cell types as well as several proteins involved in mitochondrial activity and 
biogenesis (Brooks, 2009; Hashimoto et al., 2007, 2008; Samuvel et al., 2009). Carrière 
and colleagues demonstrated that lactate increased thermogenic gene expression in 
murine and human white adipocytes through Pparγ-dependent signaling (Carrière et al., 
2014).   
7. Metabolic Control of Epigenetics  
Much of the information, regarding when and where to initiate transcription, are 
stored in covalent modifications of DNA and its associated proteins. The pattern of 
various modifications along the chromatin, such as DNA cytosine methylation and 
hydroxymethylation, acetylation, methylation, phosphorylation, ubiquitination, and 
SUMOylation of the lysine and/or arginine residues of histones determines the genome 
accessibility to transcriptional machinery (Ward and Thompson, 2012). Metabolic 
pathways are increasingly recognized to facilitate epigenetic regulation of gene 
expression, impacting differentiation programs (Wellen and Thompson, 2012; Kaelin and 
McKnight, 2013).  
7.1 Acetyl-CoA and Epigenetic Regulation  
In eukaryotes, the mitochondrial processes of glucose-derived pyruvate oxidation, 
amino acid catabolism, and the oxidation of fatty acids generate acetyl-CoA (Wagner and 
Payne 2011). In general, during a state of nutrient excess, a proportion of the excess 
acetyl-CoA generated within the mitochondria is exported into the cytosol (Bauer et al., 
2005). Some of this acetyl-CoA might travel to the nucleus where it is used for histone 
acetylation, creating a direct link between metabolism and epigenetics (Wagner and 
Payne, 2011; Wallace and Fan, 2010; Wellen et al., 2009). In particular, histone 
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acetylation leads to an open euchromatin conformation that can regulates gene expression 
in stem cells (Roh et al., 2005; Bernstein et al., 2006; Choudhary et al., 2009; Kaelin and 
McKnight, 2013). Regulation of acetyl-CoA through changes in glycolysis may 
contribute to epigenetic control of cell fate (Cai et al., 2011; Friis et al., 2009; Wellen et 
al., 2009). For example, glycolysis is thought to fuel the rise in acetyl-CoA and histone 
acetylation required for adipocyte differentiation (Wellen et al., 2009). In this case, 
during adipogenesis, activation of a lipogenic program increases glucose metabolism 
which fuels a rise in acetyl-CoA that is necessary for increased histone acetylation. This 
results in the transactivation of key metabolic proteins such as Glut4, hexokinase 2, 
phosphofructokinase 2 (Pfk2), and Ldh (Wellen et al., 2009).  
7.2 α-ketoglutarate and Epigenetic Regulation 
Similarly to acetyl-CoA, α-ketoglutarate can exit the mitochondria to function as 
a cofactor for enzymes, including the Jumonji-family of histone demethylases, the ten-
eleven translocation (TET) family of DNA hydroxylases, which convert 5-
methylcytosine to 5-hydroxymethylcytosine, and prolyl hydroxylases (PHDs) that control 
HIF1α transcription factor stability (Xu et al., 2011; Kaelin and McKnight, 2013). 
Specifically, in HSCs, MSCs, and neural progenitor cells, mutations in either isoform of 
isocitrate dehydrogenase (Idh), which reduces the availability of α–ketoglutarate while 
producing 2-hydroxyglutarate (2-HG), alter DNA and histone modifications causing 
premature differentiation and cancer (Figueroa et al., 2010; Sasaki et al., 2012; Lu et al., 
2012). Moreover, expression of mutated Idh1 and/or Idh2, or TET depletion, impairs 
haemtopoietic differentiation and is accompanied by increased HSC self-renewal 
(Figueroa et al., 2010; Cimmino et al., 2011). Additionally, fluctuations in α-
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ketoglutarate can also alter gene expression by decreasing HIF1α stability. In the 
presence α-ketoglutarate PHDs catalyse HIF1α hydroxylation, priming the protein for 
degradation. Increased HIF1α activity promotes an oxidative metabolism to glycolytic 
switch through transcriptional activation of genes such as Glut1 Ldha and Pdk1 (Suda et 
al., 2011; Zhou et al., 2012). 
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8. RATIONALE & OBJECTIVES 	  
8.1 Rationale 
The transcriptional co-repressor p107 has been shown to determine the fate of adult stem 
cells and their progenitors in a cell autonomous manner. Depletion of p107 in primary 
myoblasts and MSCs leads to formation of oxidative tissues, such as slow skeletal muscle 
fibers and brown and beige adipocytes, respectively (Scimè et al., 2005, 2010 ; De Sousa 
et al., 2014). Currently, there is no clear mechanism for how p107 protein levels can 
determine the fate of the adult stem cells. Intriguingly, one emergent mechanism for stem 
cell fate determination involves bioenergetics, that beyond providing fuel for a cell, is 
capable of engaging master genetic programs during stem cell fate decisions (McKnight, 
2010).  
8.2 Hypothesis 
We hypothesize that p107 determines the fate of stem cells and their progenitors to the 
white versus brown-type adipocyte lineage by controlling the bio-energetic status.  
8.3 Purpose 
The purpose of this thesis is to characterize the metabolic role of p107 function in 
adipocyte lineage commitment. 
Specific Objectives  
1. To determine the mechanism(s) of p107 action during stem cell commitment by: 
a. Establishing the functional activity of p107 during stem cell commitment  
b. Assessing the effect of p107 activity on specific bioenergetics pathways 
c. Testing the influence of bioenergetics on stem cell commitment 	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9. MATERIALS & METHODS 	  
Mice and dissections  
All animal experiments were performed according to procedures approved by the 
institutional Animal Care Committee of York University. All experimental procedures 
were performed in adult (8 to 16 week old) mice of the Balb/c genetic background, 
including p107 KO mice (LeCouter et al., 1998). Mice were maintained on a standard 
rodent chow diet with 12-hour light and dark cycles.   
Adipose depots for analysis were dissected as follows: Inguinal WAT, bilateral 
subcutaneous WAT depots between the skin and muscle fascia just anterior and posterior 
to the lower segment of the hind limbs and interscapular WAT, posterior bilateral 
superficial WAT depots between the skin and muscle fascia flanking either side of the 
BAT depot.  
Cell types used 
C3H10T1/2 cells are an MSC line obtained from the American Type Culture Collection. 
Flag tagged Prdm16 (Prdm16-Flag) and control (MSC-Ctl) cell lines were from De Sousa 
et al. (De Sousa et al., 2014). 
 MEFs, representing an enriched source of primary mesodermal stem cells, were isolated 
from embryos of a heterozygous p107 KO mating pair at 14.5 days post coitum. Embryos 
were dissected and the placenta removed. Ectodermal and endodermal cells located 
within heads, tails, and internal organs were discarded and some tissue saved for 
genotyping.  The remaining mesodermal tissue was minced in 5mL of trypsin, 
resuspended in Dulbecco’s modified eagle medium (DMEM) with 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin, plated and allowed to grow.  
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Isolation of the SVF was performed by dissecting specific adipose depots as described 
above, minced and digested with 1mg/ml collagenase I (Sigma) in 10% FBS at 37°C for 
45 minutes (min).  To recover the cells after digestion, the cell digested slurry was passed 
through a 100 µm cell strainer and cells were pelleted by centrifugation at 250g for 5 min. 
C3H10T1/2 cells are an MSC line obtained from the American Type Culture Collection. 
Virus production and Cell line derivation 
For p107 short hairpin (sh) RNAi and control virus production, 293FT cells were 
transfected using Lipofectamine 2000 (Life Technologies) with p107 sh RNAi 
(TRCN0000218550; Sigma-Aldrich) or control scrambled p107 sh RNAi (Sigma-
Aldrich) lentiviral plasmids, with packaging vectors according to manufacturer’s 
protocol. 18 hours post transfection cells were washed and at 48 and 72 hours media 
containing virus was collected.  
For transducing cells, 10 ml of the various collected viral media was added to 
C3H10T1/2 cells with 8 µg/ml of polybrene.  After 24 hours cells were washed and re-
fed for cell line derivation. Cell lines were selected with 2mg/ml puromycin to produce 
Control (Ctl) and p107 KD. 
Cell culture and adipocyte differentiation 
All cells were grown in DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin.  MEFs, SVF or C3H10T1/2 cells were differentiated to 
adipocytes after reaching confluency to induce quiescence through contact inhibition, for 
24 hours (time 0) according to the standard differentiation protocol (De Sousa et al., 
2014). At time 0, DMEM with 10% FBS and 1% penicillin/streptomycin was 
supplemented with 0.5 mM isobutylmethylxanthine, 125 nM indomethacin, 1uM 
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dexamethasone, 850 nM insulin, 1nM triiodothyronine (T3), and 1 uM rosiglitazone for 2 
days. At day 2, cells were switched to maintenance medium containing 10% FBS, 1% 
penicillin/streptomycin, 850 nM insulin, 1 nM T3, and 1 uM rosiglitazone for 5 days.  
Additionally, C3H10T1/2 cells were treated with 40mM oxamate (Sigma) or with vehicle 
DMSO at confluency for 24hrs and then washed and differentiated to adipocytes as 
described above.  
Cell-cycle analysis 
C3H10T1/2 cells and Wt MEFs were first washed twice with PBS, and centrifuged at 
1500 rpm for 5 min at RT.  The cell pellet was washed twice with ice-cold PBS and 
resuspended in 1mL of ice-cold PBS. This was added drop wise to 4mL of ice-cold 
absolute ethanol while vortexing. Cells were then fixed for 20 min at -20°C. 
Subsequently, the cells were pelleted by centrifuged at 1500 rpm for 5 min, and 
resuspended in 1mL of staining buffer (100mM Tris, pH 7.4, 150 mM NaCl, 1mM CaCl2, 
0.5 mM MgCl2, 0.1% Nonidet P-40) containing 3µM of propidium iodine (Life 
Technologies) and 10ug/mL RNase A (Roche). All samples were analyzed by FACS 
analyses (FACSCalibur, BD Biosciences). 
Protein Isolation 
Cells in culture were lysed in RIPA buffer (0.5% NP-40, 0.1% sodium deoxycholate, 150 
mM NaCl, 50 mM Tris-Cl pH 7.5) containing protease inhibitor cocktail (Roche) for 10 
min on ice. The lysate was clarified by centrifugation at 13,000g for 10 min at 4°C.  
Nuclear-Cytoplasmic Extraction  
Monolayer cells were first washed twice with PBS, and then harvested by gentle scraping 
in ice-cold PBS containing protease inhibitors (Roche) and centrifuged at 1500 rpm for 5 
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min at RT. The supernantant was then discarded and the cell pellet was washed by 
suspending the cells with ice-cold PBS containing protease inhibitors (Roche) and 
transferred to a new 1.5 ml microcentrifuge tube and again pelleted by centrifugation at 
2500g for 3 min. The cell pellet was then resuspended in 500uL cytoplasmic lysis buffer 
(10mM Tris pH 7.4, 10mM NaCl, 3mM MgCl2, 0.5% NP-40 and protease inhibitors) and 
incubated on ice for 5 min followed by rocking at 4° for 5 min. After incubation, a small 
volume (150uL) of the homogenate mixture was removed. This fraction represented the 
“whole cell lysate”. The remaining homogenate was then centrifuged at 2500g for 5 min 
at 4oC. The supernatant, which represented the cytoplasmic extract, was then transferred 
to a clean pre-chilled tube. The cell pellet containing intact nuclei was then washed with 
the cytoplasmic lysis buffer. After 10 washes, the insoluble cell pellet was lysed with 
nuclear lysis buffer (50mM Tris pH 7.4, 5mM MgCl2, 0.1 mM EDTA, 1mM 
dithiothreitol (DTT), 40% (wt/vol) glycerol) containing 0.15 unit/ul benzonase 
(Novagen) to digest the DNA and RNA in the suspension.  
Western blot analysis 
For Western blot analysis protein lysates were loaded onto polyacrylamide gels, ranging 
from 6%-15% acrylamide, and Western blotted according to standard protocol (De Sousa 
et al., 2014).  Samples to be loaded were first boiled for 3 min in loading buffer 
containing 4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, 
0.125 M Tris-HCl, and 1mM DTT.	  20µg of sample was loaded onto 7.5% SDS 
polyacrylamide gels or 25µg was loaded onto gradient gels (6 to 15%) for subcellular 
localization of p107.  The proteins were separated by electrophoresis for 2 hours at 30 
milliamps per gel at RT.  Proteins were transferred on a 0.45 a polyvinylidene difluoride 
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(PVDF) membrane (Bio-Rad) at 4 °C for 120 min at 100V, using a wet transfer method. 
After blocking for 60 min at RT in 5% non-fat milk in Tris-buffered saline (TBS; 150mM 
NaCl and 50mM Tris base) containing 0.1% tween (TBST), the PVDF membranes were 
probed with antibodies diluted in 5% non-fat milk in TBST.  Incubation with primary 
antibodies was performed overnight at 4 °C and with gentle rocking. Antibodies used 
were rabbit polyclonal C18 anti-p107 (Santa Cruz), anti- α-tubulin (Sigma-Aldrich), and 
anti-Histone H3 (Santa Cruz). Membranes were then washed with TBST and probed for 
60 min at RT with gentle rocking with the appropriate secondary antibodies diluted in 5% 
non-fat milk in TBST. Secondary antibodies conjugated with horseradish peroxidase 
were goat anti-rabbit (Bio Rad), goat anti-mouse (Bio Rad) and rabbit anti-goat (Bio Rad) 
and blots were visualized with chemiluminescence on photographic film. Protein levels 
were then evaluated through densitometry using Image J software. 	  
qPCR Analysis  
For RNA isolation, cells were first lysed in RNA Lysis Buffer (FroggaBio) and RNA 
purified using the Total RNA mini kit (FroggaBio) according to the manufacturer’s 
instructions. For RNA isolation from adipose tissue, 500 mg of isolated tissue was 
homogenized using the cell disruptor Retsch MM400 with two beads in 1 mL TRIzol 
(Invirtogen). The lysate was then centrifuged for 10 min at 13,000g at 4°C and the lipid 
layer and pellet were discarded. RNA was then extracted from the supernatant according 
to the manufacturer’s instructions (Invirtogen). 1µg of RNA was reversed transcribed into 
cDNA using the GeneAmp Kit (Applied Biosystems). Reverse transcribed RNA (25ng) 
was used for PCR analysis. The Quantitative Real Time PCR (qPCR), assays were 
performed on the ABI 7500 Fast cycler (Invitrogen) and LightCycler 96 (Roche) using 
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SYBR green PCR Master mix (Invitrogen and Roche) with primer sets listed in Table 1. 
Relative expression of cDNAs was determined after normalization with β-actin using the 
ΔΔCt method.  
Quantitative Chromatin Immunoprecipitation Assay 
qChIP assay was performed on Prdm16-Flag cells and control cell line MSC-Ctl  (De 
Sousa et al., 2014) with an assay kit (Millipore) according to the manufacturer's 
instructions. Chromatin was crosslinked by formaldehyde incubation and cells were 
scraped in PBS containing 100 mM Na3VO4 and 1 mM NaF then pelleted by 
centrifugation followed by resuspension in SDS lysis buffer containing protease 
inhibitors (Roche). Crosslinked chromatin was sheared using a Bioruptor (12 cycles, 15 s 
shearing, 45 s at rest, 4 °C) to obtain DNA fragments to an average size 400–600 bp. One 
tenth of lysate was used for input and the rest was used for ChIP. Samples were pre-
cleared (60 min, 4 °C) with protein A/G agarose beads (Upstate Biotechnology) then 
incubated with anti-E2F1 (Santa Cruz; sc-193) or M2 anti-Flag (Sigma) for 24 hrs. The 
immune complexes were collected by adsorption to protein A/G agarose beads (2 h, 4 
°C). Beads were washed and samples eluted according to the manufacturers instructions. 
After purification using the Chromatin IP DNA Purification Kit (Active Motif) DNA 
fragments were amplified by PCR reaction. ChIP primer sets amplified the promoters of 
p107 (−214 to −32) forward primer cccgagctagatctccgtta and reverse primer 
ggcttcggggttttctttt or positive control angiotensinogen (Agt) (−127 to +23) forward 
primer cttggtcaagcctggattctc and reverse primer ccaacctagacaagcacagctatc. The PCR 
conditions were 40 cycles for 30 seconds at 95°C denaturation, 30 seconds at 56°C 
annealing, and 30 seconds at 72°C extension.  
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Measurement of mitochondrial O2 respiration  
Cells in proliferation, G0/G1, day 3 or day 7 of adipocyte differentiation, were first 
counted, resuspended in mitochondrial respiration media (MiRO5) composed of 130 mM 
sucrose, 60 mM K-MES, 1 mM ethylene glycol tetraacetic acid, 3 mM MgCl2, 10 mM 
K2HPO4, 20 mM HEPES, 1 mg/ml bovine serum albumin (pH 7.4), and permeabilized 
with 40 mg/ml saponin for 10 minutes at 37◦C rotation. Importantly, optimization of 
saponin concentration was performed by comparing the effect of a range of Saponin 
concentrations on State 3 respiration with exogenously added mitochondrial membrane 
intactness factor Cyt c for all cell types used. After permeabilization, high resolution 
respirometry was conducted at 37◦C with the Oxygraph-2K (Oroboros) on 106 
cells/chamber in MiRO5 buffer. For measurement of ADP- dependent OXPHOS (State 3 
respiration) the following were added sequentially: (a) 5 mM glutamate + 2 mM malate 
(NADH generation for complex I-supported respiration), (b) 4 mM ADP, (c) 5 mM 
pyruvate (complex I substrate), and (d) 5 mM succinate (FADH2 generation for complex 
II supported respiration). Two methods were used to assess mitochondrial O2 
consumption due to proton leak. First, measurements were made in the absence of ADP- 
stimulation of ATP synthase (State 2 respiration) with the addition of 5 mM glutamate 
and 2 mM malate to the permeabilized cells. Second, 10 mg/ml oligomycin was added, 
after the addition of the complex I and II components of State 3, as above. For 
measurement of β-oxidation the following were added sequentially: a) 2mM L-carnitine 
(L-carn) (fatty acid substrate) + 1 mM malate (complex I substrate), b) 100µM palmitoyl 
coenzyme A (PCoA).  
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Oil Red O Staining  
After 7 days of differentiation, cells were fixed in 10% formaldehyde for 10 min at room 
temperature (RT), washed with water and then stained with Oil Red O solution for 20 
min at RT. Oil Red O staining solution was composed of 6 volumes of stock solution 
containing 0.5g Oil Red O (Sigma) and 100 ml isopropanol with 4 volumes of distilled 
water.  
Microscopy & Digital Images 
Images were obtained using the Axiovert 40C Carl Zeiss microscope with ×20 0.30 LD 
A-Plan Ph1 Var1 objective. Digital images were captured using the Power Shot G5 
camera with conversion lens adaptor LA-DC8B, 58–52 mm (Canon). Digital images of 
stained culture plates were captured by scanner using CanoScan LiDE 700F (Canon). 
Statistical Analysis 
All statistical analyses were performed on GraphPad Prism version 6.03. Student’s paired 
t-tests were used unless otherwise stated. Results were considered to be statistically 
significant when p < 0.05. Specific data was analyzed using an appropriate one- or two-
way analysis of variance (ANOVA) with a criterion of p<0.05. All significant differences 
for ANOVA testing were evaluated using a Tukey HSD post-hoc test. For these graphs, a 
different letter denotes a significant difference between groups. All data are mean ± 
standard deviation (SD).  
 
 
 
 
35	  	  
	   	  
Table 1 – List of Primers used in qPCR analysis  
 
 
  
Primers  Forward Primer (5’ – 3’)  Reverse Primer (3’ – 5’)  
Prdm16 CAGCACGGTGAAGCCATTC GCGTGCATCCGCTTGTG 
Adipoq GCACTGGCAAGTTCTACTCAA GTAGGTGAAGAGAACGGCCTTGT 
Fabp4 ACACCGAGATTTCTTCAACTG CCATCTAGGGTTATGATGTCTTCA 
Pparγ CAGGCTTGCTGAACGTGAAG GGAGCACCTTGGCGAACA 
Ucp1 ACTGCCACACCTCCAGTCATT CTTTGCCTCACTCAGGATTGG 
Cidea  TGCTCTTCTGTATCGCCCAGT GCCGTGTTAAGGAATCTGCTG 
Cox8b GAACCATGAAGCCAACGACT GCGAAGTTCACAGTGGTTCC 
Elovl3 TCCGCGTTCTCATGTAGGTCT GGACCTGATGCAACCCTATGA 
Pgc-1α CCCTGCCATTGTTAAGACC TGCTGCTGTTCCTGTTTTC 
β-actin GCTCTGGCTCCTAGCACCAT CCACCGATCCACACAGAGTAC 
Mal-aKG 
antiporter 
ATTGCCAGGGAAGAAGGAGT CATGGAAGCAGCAGTGGTAA 
Mdh1 CCAGAGGGAGAGTTCGTGTC AAAGCGGTCTCCTTTTCCTC 
Mdh2 AGCAGGTTCTGCCACTCTGT AGGAGTGATCTTGCCAATGC 
GOT1 TATCAGGGAGAATCGGGTTG TAGCAATAGGGCCGAATGTC 
GOT2 GTTGAAATGGGACCTCCAGA GGGCAGGTATTCTTTGTCCA 
Glu-Asp  
Pore 
AGGCTCGCAGGTCATCTTTA GTGAGCGTACACGGGAAAAT 
LDHa CCGTTACCTGATGGGAGAGA GTAGGCACTGTCCACCACCT 
PDK2 CTGGACCGCTTCTACCTCAG GTTGGTGGCATTGACTTCCT 
FATP4 ATTTTCGAGGGCACAGACAC CGCCTAAGGTTGGTGTTGAT 
CPT2 TCCTCGATCAAGATGGGAAC GATCCTTCATCGGGAAGTCA 
CAT AGACTGCACCTCCTGGAAAA ATGGCAATTTCAAAGCCAAG 
CPT1b GTCGCTTCTTCAAGGTCTGG AAGAAAGCAGCACGTTCGAT 
CPT1c GGAAGGCAGGACAGAGACAG CGGGACATGATGTACAGTGC 
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10. RESULTS  	  
p107 KO SVF cells readily differentiate into brown-type adipocytes 
Work from our lab has shown that p107 is uniquely expressed in the SVF of 
adipose tissue, that contains stem cells and their progenitors, but not in the terminally 
differentiated adipocyte fraction (De Sousa et al., 2014). Moreover, the lower expression 
levels of p107 are correlated with higher levels of brown-type adipocytes in adipose 
tissue depots (Scimè et al., 2005, 2010; De Sousa et al., 2014). We tested whether p107 
expression levels control adipocyte lineage commitment in primary adult stem cells in an 
autonomous manner. For this, the differentiation potential of SVF cells from 
subcutaneous fat pads of (Wt) compared to p107 KO mice was assessed. Oil Red O 
staining 7 days post-differentiation revealed that adipocyte differentiation was somewhat 
higher for the SVF of p107 KO as compared to Wt mice (Figure 6A). Gene expression 
analysis of general adipogenic markers Adipoq and Fabp4 showed no difference in 
levels, but Pparγ levels were significantly increased in the differentiated SVF of p107 
KO mice (Figure 6B). This increase might be reflective of the known enhanced adipocyte 
differentiation capacity of p107 KO SVF cells (Scimè et al., 2005). Importantly 
adipocytes derived from p107 KO mice had at least an eleven-fold significantly (p 
<0.001) higher gene expression level of the brown-type adipocyte marker Ucp-1 (Figure 
6C). Convincingly, the thermogenic character of these cells showed significantly higher 
expression levels of other brown-type markers, Cidea (p<0.0001), Cox8b(p<0.0001), 
Elovl3(p<0.01), Pgc-1α(p<0.0001) and Prdm16(p<0.0001) (Figure 6C). These results 
suggest that p107 functions in primary adult stem and/or progenitor cells to block brown-
type adipocyte differentiation. 
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Prdm16 regulates p107 gene expression directly 
 We investigated the potential upstream control of p10 in brown-type adipocyte 
determination. The brown fat determination factor, Prdm16, down regulates both p107 
protein and mRNA levels (De Sousa et al., 2014). Using a qChIP assay we assessed 
Prdm16-bound DNA regions on the p107 promoter. In these experiments, C3H10T1/2 
cells expressing Flag tagged Prdm16 (Prdm16-Flag) or control vector (MSC-Ctl) cell 
lines (De Sousa et al., 2014) were immunoprecipitated and purified using anti-Flag 
antibodies (Figure 7A). Prdm16 specific binding was evaluated by qPCR with primer sets 
within the 900 base pair (bp) promoter of p107 and to the positive control promoter, 
angiotensinogen (Agt) (Kajimura et al., 2008). An E2F1 immunoprecipitation was used 
as a positive control for interaction at the p107 promoter (Figure 7B). As expected, E2F1 
bound to the p107 promoter in C3H10T1/2 cells and not to the Agt promoter (Figure 7C). 
Importantly, Prdm16 was enriched at both the p107 and Agt promoters, but only in the 
cells engineered to express Flag-Prdm16 (Figure 7D). Together, these data suggest that 
Prdm16 directly down regulates p107 gene expression during the commitment stage of 
brown-type adipocyte development.  
p107 is active in G0/G1 after nuclear translocation  
We also wanted to find the downstream mechanism for how p107 functions in 
adipocyte lineage fates of stem cells.  We first determined its potential activity during the 
earliest phases of differentiation, at confluency before addition of differentiation media 
when lineage fate choices are made. As p107 is a transcriptional co-repressor, we 
assessed its subcellular localization and protein levels in the stem cell line, C3H10T1/2, 
and primary MEFs, an enriched source of mesodermal stem cells and progenitors. By 
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western blotting of cytoplasmic and nuclear fractions, we found that it is almost 
exclusively expressed during proliferation in the cytoplasm of both MEFs and 
C3H10T1/2 cells (Figure 8A and 8B). However, as the cells become confluent, p107 
translocates transiently into the nucleus becoming negligible after 24 hours and is barely 
existent at 48 hours (Figure 8A and 8B). The timing of p107 nuclear localization 
corresponds to the time point when cells are contact inhibited before the addition of 
adipocyte differentiation media. 
We next assessed the cell cycle phases for C3H10T1/2 cells and MEFs, during the 
same time points that had been done for the subcellular localization experiments. Using 
flow cytometric analysis with propidium iodide DNA staining, we found that during 
proliferation, the cells are mainly in S phase (Figure 8C). Importantly, when either 
C3H10T/2 cells or MEFs reached confluency, they entered a non-proliferative G0/G1 
state (Figure 8C). This is the time point when adipocyte differentiation media is added to 
promote efficient differentiation.  
p107 influences cellular respiration  
We assessed the influence of p107 on bioenergetics by first testing the oxidative 
capacity of p107 KO and Wt MEFs. Using high resolution respirometry of permeabilized 
cells during proliferation, G0/G1 and 3 and 7 days post adipocyte differentiation was 
measured using an Oroboros Oxygraph-2k. Substrates were added in a sequential order to 
activate various components of the ETC (Figure 9A). ADP-stimulated respiration (State 3 
respiration), supported by both complex I and complex II substrates glutamate and 
malate, (GM), with pyruvate, (GMP) and together with succinate (GMPS), resulted in 
significantly greater oxygen consumption in p107 KO MEFs compared to Wt control 
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cells at G0/G1 (p<0.001, GM3; p<0.001, GMP3; p<0.01, GMPS3) and 3 (p<0.0001, GM3; 
p<0.01, GMP3; p<0.05, GMPS3 ), and 7 (p<0.001, GM3; p<0.05, GMP3; p<0.05, 
GMPS3 ) days post differentiation (Figure 9B). Notably, during the proliferative state, 
there tended to be minimal differences in the oxidative capacity of p107 KO stem cells in 
comparison to control cells (Figure 9B). Moreover, p107 KO MEFs exhibited greater 
uncoupled respiration than control cells when treated with substrates for complex I (GM) 
or both complex I and II substrates (GMPS) with oligomycin, during each time point 
(Figure 9B). Taken together, this data indicates that both the oxidative and thermogenic 
capacities of p107 KO MEFs are significantly enhanced during differentiation as well as 
in G0/G1 before the addition of differentiation media. 
In order to discriminate against any possible developmental effects caused by 
chronic loss of p107 in MEFs and to better maintain a homogenous population of cells, 
we assessed the influence of p107 on bioenergetics with p107 KD C3H10T1/2 cell lines 
compared to their controls. We used lentivirus to deliver a short hairpin sequence for 
targeting p107 mRNA (shp107) or a non-targeting scrambled control to produce cell lines 
designated p107 KD and control (Ctl), respectively. Western blot analysis revealed that 
p107 protein levels were significantly (p< .0001) reduced by as much as 95% with 
expression of shp107 in comparison to untransduced cells and Ctl (Figure 10A).  
The oxygen consumption of p107 KD cells compared to their controls was 
assessed during proliferation, G0/G1 and, 3 and 7 days post differentiation, as was done 
for the MEFs in Figure 9. Corroborating the p107 KO MEF results, high resolution 
respirometry revealed that during State 3 respiration, the p107 KD cells had significantly 
greater oxygen consumption than control cells at G0/G1 (p<0.001, GM3; p<0.05, GMP3) 
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and at 3 (p<0.001, GM3; p<0.01, GMP3; p<0.01, GMPS3) and 7 (p<0.0001, GM3; 
p<0.0001, GMP3; p<0.0001, GMPS3) days post differentiation (Figure 10B). Again as 
with the MEFs, during the proliferative state, there were no differences in the oxidative 
capacity of p107 KD stem cells in comparison to control cells (Figure 10B). In addition, a 
greater respiration due to proton leak occurred when supported by oligomycin for each 
day in differentiation (Figure 10B). Together, these data confirm that the oxidative and 
thermogenic capacities of the p107 KO and KD stem cells during differentiation are 
significantly enhanced beginning at G0/G1 before addition of adipocyte differentiation 
media and during adipocyte differentiation. 
p107 KO and KD stem cells have altered NADH partitioning in G0/G1 
 We tested if p107 KO and KD stem cells had a better coupling of glycolysis and 
TCA that might potentially account for the increased respiration in G0/G1. We first 
assessed, for p107 KO and Wt MEFs, the gene expression of components of the malate-
aspartate shuttle system, which provides the essential reducing equivalents from 
glycolysis to the ETC (Figure 4). As anticipated, we found no significant differences in 
components of the shuttle during the proliferative state (Figure 11A). Surprisingly, gene 
expression levels of key components of the shuttle system were significantly reduced 
including the Glu-Asp pore (p<0.05), Mal-aKG pore (p<0.01), and Mdh1 (p<0.05) in 
p107 KO stem cells in comparison to control cells at G0/G1(Figure 10B). We also 
performed this analysis on p107 KD cells compared to control cells in G0/G1 and during 
proliferation. We found that during proliferation there were no differences in the gene 
expression pattern of the malate-aspartate shuttle between p107 KD and control cells, 
corroborating the results with MEFs (Figure 11A and Figure 11C). However, we found 
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significantly reduced gene expression levels of the Glu-Asp pore (p<0.05), Mal-aKG 
pore (p<0.05), and Mdh1 (p<0.01) in p107 KD cells in comparison to control cells at 
G0/G1 (Figure 11D).  
p107 KO and KD stem cells participate in anaerobic glycolysis at G0/G1 
 Glycolytic coupling to the TCA and ETC was further analyzed by assessing key 
components of pyruvate oxidation. We first assessed Ldha that promotes the conversion 
of pyruvate to lactate transforming NADH to NAD+, which is used in glycolysis. Gene 
expression analysis by qPCR showed significantly (p<0.05) increased Ldha expression in 
p107 KO MEFs at G0/G1 in comparison to Wt, and to p107 KO MEFs and Wt cells 
during proliferation (Figure 12A). Additionally, by Western blotting, p107 KO MEFs had 
significantly (p<0.001) increased Ldha protein levels at G0/G1 in comparison to Wt cells, 
and to both Wt and p107 KO MEFs during proliferation (Figure 12B).  
Comparing p107 KD cells versus control cells during G0/G1 and proliferation 
corroborated the results for MEFs. We found significantly (p<0.01), increased levels of 
Ldha, gene expression by qPCR for p107 KD in G0/G1 compared to controls and to both 
p107 KD and control cells during proliferation (Figure 12C).  By Western blotting, we 
also found significantly (p<0.01) increased levels of Ldha, protein for p107 KD in G0/G1 
compared to control cells and to both p107 KD and controls during proliferation (Figure 
12D).  
We also tested the gene and protein expression of PDK2, which inhibits the 
activity of PDH responsible for transforming pyruvate into acetyl-CoA. qPCR analysis 
revealed that PDK2 gene expression was significantly increased (p<0.05) in p107 KO 
stem cells in comparison to Wt cells, as well as p107 KO MEFs and Wt cells during 
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proliferation (Figure 13A).  Moreover, protein levels were also significantly increased 
(p<0.001) in p107 KO MEFs at G0/G1 in comparison to Wt cells (Figure 13B). Notably, 
this increase only occured at G0/G1 as there were again no significant differences in 
PDK2 gene and protein levels between p107 KO and Wt during a proliferative state 
(Figure 13B).  
p107 KD cells, in comparison to control cells at G0/G1 and versus p107 KD cells 
and controls during proliferation, also showed a significant increase in both PDK2 gene 
(p<0.05) and protein levels (p<0.01) (Figure 13C and 13D). This verified our previous 
results obtained from the p107 KO MEFs. Again, there were no significant differences in 
PDK2 gene and protein levels between p107 KO and control cells during proliferation.  
p107 KD cells have enhanced β-oxidation in G0/G1 
 We also assessed the capacity of β-oxidation that might potentially account for the 
increased respiration in G0/G1 for p107 KO and KD cells. To accomplish this, we used 
high resolution respirometry and stimulated β-oxidation by adding the following 
substrates sequentially: fatty acid substrate L-carn, malate a complex I substrate, and fatty 
acid substrate PCoA (Figure 14A). As anticipated, there were no significant differences 
between p107 KD and control cells during proliferation, but at G0/G1 p107 KD cells 
demonstrated significantly (p<0.05) enhanced β-oxidation (Figure 14B).  
We also tested for various components of fatty acid transport and metabolism to 
determine if they might have contributed to the enhanced β-oxidation in p107-depleted 
stem cells at G0/G1. qPCR gene expression analysis revealed that p107 KD compared to 
control cell lines had increased components of fatty acid transport and metabolism in 
G0/G1 (Figure 14C). Specifically, p107 KD stem cells had a 7-fold increase in Fatp4 
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(p<0.05) and 4-fold increase of Cpt2 (p<0.05), whereas there were no significant 
differences between p107 KD cell in comparison to control cells during proliferation.  
Anaerobic glycolysis in G0/G1 is necessary for brown-type differentiation  
To explore how altered bioenergetics affect adipocyte lineage fates through p107, 
we used the chemical oxamate that inhibits Ldha and thus glycolysis in adipocyte 
differentiation assays. Oil Red O staining 7 days post-differentiation of p107 KD and 
control cells revealed that adipocyte differentiation was unaffected by oxamate treatment 
(Figure 15A). In support of our published data (De Sousa et al., 2014), the p107 KD cells 
had a significantly higher expression level of Ucp-1 (p<0.05) 7 days post differentiation. 
However, inhibition of anaerobic glycolysis via oxamate administration prevented the 
brown-type differentiation potential of p107 KD stem cells (Figure 15B). There were no 
significant increases in Ucp-1 gene expression in both treated and untreated control cells 
(Figure 15B).   	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11. DISCUSSION 	  
In this study, we provide mechanistic evidence for how the transcriptional co-
repressor p107, acts as an adipocyte lineage determinant factor. The importance of p107 
in adipocyte fat lineage decisions in a stem cell-autonomous manner is assured by our 
assessment of the differentiation capacity of primary stem and progenitor cells. For this 
we used the SVF of adipose depots from mice that contain the cells that might become 
adipocytes during its lifetime. Contrary to their Wt controls, SVF cells of p107 KO mice 
have the ability to differentiate into brown adipocytes, confirmed by the expression of 
Ucp-1 and other pro-thermogenic markers (Figure 6C). A result that corroborates the data 
obtained from both p107 KO MEFs and p107 KD stem cell lines (De Sousa et al., 2014).  
These results indicate that p107 acts as a crucial factor within a signaling cascade 
involved in adipose development during adulthood. This is highlighted by the down 
regulation of p107 gene and protein expression in the presence of the master regulator of 
brown-type adipocyte formation, Prdm16 (De Sousa et al., 2014). We found using qChIP 
assays that Prdm16 does this by directly binding the promoter region of p107 (Figure 
7D).  
In this study, we show for the first time that p107 controls adipocyte lineage fate 
decisions of white versus brown-type adipocytes by its nuclear re-localization during 
G0/G1 phase of the cell cycle. We demonstrated that both genetic and shRNA-mediated 
reduction of p107 in stem cells at G0/G1 resulted in profound metabolic alterations 
including anaerobic glycolysis and significantly increased respiration. Specifically, we 
found that p107 is almost exclusively expressed during proliferation in the cytoplasm of 
primary Wt MEFs and the non-committed C3H10T1/2 stem cell line (Figure 8A and 8B). 
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However, as both cell types become confluent and enter a G0/G1 state (Figure 8C), p107 
translocates transiently into the nucleus becoming negligible after 24 hours (Figure 8A 
and 8B). As p107 is a co transcriptional repressor, its nuclear translocation corresponds to 
its active role during lineage commitment. It is during this G0/G1 stage, when a cell 
makes important decisions to remain quiescent, proliferate or differentiate (Loyer et al., 
1996; Zavitz and Zipursky, 1997). Importantly, it is also the time point in which 
adipocyte differentiation is initiated (De Sousa et al., 2014; Rosen and MacDougald, 
2006). Together, this suggests that p107 functions in adipocyte lineage decisions within a 
short window, after it is translocated to the nucleus.  
During the proliferative state, there were no differences in the oxidative capacity 
of p107 KO MEFs and KD C3H10T1/2 cells in comparison to their controls (Figure 9B 
and Figure 10B). However, the difference in respiration levels became significantly 
increased in cells lacking p107 only when they entered the G0/G1 state. This suggests that 
during the non-proliferating state, p107 functions in lineage commitment to suppress pro 
thermogenic and oxidative gene expression.  
It is tempting to speculate that the higher rates of oxidation might be coupled to 
increased availability of NADH from aerobic glycolysis.  Interestingly, we found the 
malate-aspartate shuttle, which is necessary to transfer NADH from the cytoplasm to the 
mitochondria, to be deficient (Figure 11B and 11D). This inefficiency could decrease the 
capacity for the re-oxidation of NADH in the mitochondria, allowing it to be used by 
Ldha to convert pyruvate into lactate, generating NAD+ in the process, which drives 
glycolysis. This possibility was strongly reinforced by robust increases in both gene and 
protein expression levels of Ldha (Figure 12) and Pdk2 (Figure 13) in p107-depleted 
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stem cells at G0/G1. This shift in metabolism creates a Warburg-like effect in the G0/G1 
stem cells with changes in glycolytic NADH partitioning that enhances glycolysis and 
decouples it from the TCA and ETC through alterations in pyruvate metabolism. 
However, we found that glucose oxidation might be compensated by increased fatty acid 
β-oxidation during G0/G1 and that this was correlated to an increase in fatty acid transport 
protein components that could allow p107-depleted stem cells to better utilize fatty acids 
as substrates (Figure 14).  
We also demonstrated the importance of metabolic reprogramming for brown-
type adipocyte differentiation by utilizing oxamate, a chemical inhibitor of glycolysis. 
Inhibition of Ldha and thus anaerobic glycolysis by oxamate administration at G0/G1 
prevented the brown-type differentiation potential of p107 KD stem cells.  Whereas 
untreated p107 KD stem cells had a significant increase in the brown-type adipocyte 
marker, Ucp1 (Figure 15). Together, this data provides compelling evidence for the novel 
role of p107 in bioenergetic remodeling of MSCs that is required to control stem cells 
and progenitor cells in adipocyte lineage fate decisions. Indeed, Teperino and colleagues 
showed a Warburg-like metabolism in brown fat (Teperino et al., 2012). Though we are 
currently unsure of the precise mechanism by which producing a Warburg-like metabolic 
state at G0/G1 helps in commitment, future research could make use of glycolytic 
chemical inhibitors to dissect different metabolic pathways. It would be interesting to see 
if inhibition with other key glycolytic enzymes such as dichloroacetic acid, a chemical 
inhibitor of Pdk2, would prevent a brown phenotype.  
 Translocation of p107 into the nucleus correlated to its active state when it is 
bound to DNA promoters repressing gene expression. We would expect p107-binding 
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sites on promoters of pro thermogenic genes, or genes involved in bioenergetic 
remodeling. To identify p107 global binding sites across the entire genome, ChIP-
sequencing (ChIP-seq), which combines ChIP with global DNA sequencing to identify 
the genome wide binding sites of DNA-associated proteins, would need to be performed.  
The profound changes in the oxidative phenotype of the differentiated adipocytes 
emanating from p107 depleted G0/G1 state suggest that p107 might be a key player in 
epigenetic modification for stem cell commitment. For adipocyte lineage fates, 
inactivating specific genes might allow the stem cell to commit to the white versus brown 
fat lineage. On the other hand, it is conceivable that when signals are sent during the 
commitment of the stem cells to become a brown-like adipocyte, p107 is down regulated 
in order to prevent the remodeling of the chromatin on the oxidative promoters. Indeed, 
early in G1 phase of the cell cycle, p107 can complex with E2F4 and bind HDAC and 
remodel chromatin causing the repression of gene transcription (Kennedy et al., 2000; 
Macaluso et al., 2006; Zini et al., 2001; Wirt and Sage, 2010). Another important target 
of chromatin silencing is tri methylation of lysine 9 of	  histone H3 (H3K9) by the methyl 
transferase SUV39H1 (Martin and Zang, 2005). SUV39H1 is known to interact with 
p107 on promoters to target H3K9 for methylation to repress gene expression (Nicolas et 
al., 2003). Importantly, this would provide an explanation as to why p107 would be 
required to exert its effect at an early time point during the commitment of the stem cell 
and would be of little importance in an already terminally differentiated adipocyte, where 
it has been shown to no longer exist (De Sousa et al., 2014). Alternatively, different 
chromatin modification by p107 may be occurring. To ascertain if p107 functions by 
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influencing epigenetic remodeling, p107 ChIP-seq, compared to histone H3 tri methyl K9 
ChIP seq, in the absence or presence of p107 would need to be done.	   
Recent evidence suggests that the availability of the necessary metabolites in 
histone and DNA modifications modulates epigenetic alterations, providing a direct link 
between metabolic reprogramming and gene expression. For example, high levels of 
acetyl-CoA can promote histone acetylation and the activation of genes (Agathocleous 
and Harris et al., 2013). It is not clear if p107-depleted cells have elevated levels of 
acetyl-CoA. p107-depleted stem cells undergo aerobic glycolysis at G0/G1, with 
significant increases of Ldha and Pdk2, such that pyruvate is converted into lactate and 
not acetyl–CoA by Pdh. However, acetyl-CoA can be made from the conversion of 
pyruvate into oxaloacetate by carboxylase that forms citrate in the mitochondria (Cheng 
et al., 2011). The mitochondrial citrate can then be exported to the cytosol where it is 
reconverted into acetyl-CoA by ACL. This is highly relevant in that the acetyl-CoA 
groups used to modify histones are predominantly produced by ACL enzyme (Wellen et 
al., 2009). Importantly, exporting citrate to the cytoplasm may stop the TCA cycle unless 
additional pathways are engaged to supply oxaloacetate to keep the cycle going (Zaidi et 
al., 2012). Hence, a compensatory mechanism in which pyruvate is carboxylated to form 
oxaloacetate would be required in p107-depleted stem cells to maintain TCA cycling. 
Nonetheless, pyruvate might still enter the mitochondria via Pdh since increased levels of 
Pdk2 protein have not yet been correlated to increased enzymatic activity. 
Classically, p107 functions by repressing gene promoters involved in cell cycle 
progression (Zhu et al., 1993).  Moreover, shortening of the G1-phase of the cell cycle is 
caused by the down regulation of several regulators of the cell cycle including p107 
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(Pinto et al., 2008). Interestingly, the G1-phase of the cell cycle provides an opportunity 
for cells to become influenced by intrinsic and extrinsic factors, to develop new signaling 
pathways, and undergo chromatin modifications (Orford et al., 2008; Lange et al; 2010). 
Therefore, time spent at this stage might be a critical factor for cell fate changes to occur. 
Vanderluit et al. in 2007 provided evidence that a shortened G1 phase due to loss of p107 
regulates the transition from a progenitor cell to a committed neuroblast (Vanderluit et 
al., 2007). In line with this, it is reasonable to suggest that the knockdown or complete 
absence of p107 expression may result in a shortened G1 phase allowing uncommitted 
stem cells to become brown-like adipocytes. In contrast, factors involved in white 
adipocyte commitment would require a greater length of time in G1 to bring about their 
lineage-specific effects. Enhanced glycolytic flux has also been shown to trigger exit out 
of G0/G1 by regulating core components of the cell cycle machinery. Glucose can shorten 
this period by increasing the build-up of cyclin D2 (Salpeter et al., 2011). Transcriptional 
regulation of cyclin D2 is controlled by the carbohydrate response element binding 
protein (ChREP) that are regulated by several glucose-derived metabolites, including 
glucose-6-phosphate, and fructose 2,6 biphosphate (Metukuri et al., 2012; Diaz-Moralli et 
al., 2012; Arden et al., 2012). This has only be characterized in hepatocyte and the beta-
cells of the pancreas. Yet, it is plausible that anaerobic glycolysis depicted in p107-
depleted stem cells, may be another contributing factor in shortening G1 phase allowing 
the uncommitted stem cells to become brown-like adipocytes.  
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12. CONCLUSION 	  
Given its integral role in regulating systemic metabolism and energy homeostasis, 
it is no surprise that adipose tissue, consisting of white, brown and beige adipocytes, has 
become an important therapeutic target in the battle against obesity and its associated 
metabolic diseases. Thermogenic and highly oxidative brown and beige adipocytes have 
been shown to protect animals against obesity and improve glycemic control. Hence, 
encouraging stem cells to preferentially differentiate into this type of fat represents a 
promising treatment strategy. In recent years, there has been an emerging realization that, 
in addition to growth factors and extracellular matrix cues, metabolic pathways may also 
provide important signals that regulate stem cell fate decisions. Though little is known 
about the mechanisms that commit stem cells toward different adipocyte lineages, still 
less is known about metabolic regulation in adipocyte lineage determination. Once 
thought to be a mere consequence of the state of a cell, metabolic regulation, as 
evidenced by this study, plays a pivotal role in dictating adipocyte lineage fate decisions 
(Figure 16). Here we show for the first time that p107 controls adipocyte lineage fate 
decisions of white versus brown-type adipocytes by its nuclear re-localization that results 
in regulating the bioenergetic status of stem and progenitor cells during G0/G1 phase of 
the cell cycle. Nevertheless, the precise mechanism for how p107 functions during 
lineage commitment of adipocytes remains to be elucidated. Future experiments should 
focus on elucidating the mechanism of p107 translocation as well as its promoter targets 
once in the nucleus. 
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13. FIGURES 	  	  
 
Figure 1. Diagram depicting the components of the ETC. See text for more detail.  	  
 
Figure 2. External cues define the metabolic character for how a stem cell will behave 
when activated. See text for more details. 
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Figure 3. Diagram representing key enzymes in anaerobic glycolysis. See text for more 
details  
 
Figure 4. Diagram representing the malate-aspartate shuttle. See text for more detail. 
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Figure 5. Diagram representing fatty acid transport into the mitochondria. See text for 
further details.  
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Figure 6. p107 KO stromal vascular fraction (SVF) cells readily differentiate into 
brown-type adipocytes. (A) Representative oil Red O staining of Wt and p107 KO SVF 
cells after 7 days of adipocyte differentiation (scale bar = 250m). (B) Gene expression 
analysis by qPCR for general adipogenic differentiation markers, Adipoq, Fabp4, and Ppar  
(p< .001), in Wt and p107 KO SVF cells after 7 days of adipocyte differentiation (n=3). (C) 
Gene expression analysis by qPCR for general brown-type adipocyte differentiation markers, 
Ucp1, Cidea, Cox8b, Elovl3, Pgc-1, and Prdm16 after 7 days of adipocyte differentiation of 
Wt and p107 KO SVF cells (n=3, asterisks denote significance, **p<0.01, ****p<0.0001). 
All data are mean +/- SD. 
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Figure 7. Prdm16 regulates p107 gene expression. (A) and (B) Diagram showing anti-
Flag  and E2F1 antibodies interacting with Prdm16 and E2F1, respectively at the p107 
promoter. (C) Quantitative chromatin immunoprecipitation (qChIP) analysis for E2F1 in 
MSC-Ctl cells amplified with primers for the gene promoters of p107 or negative control 
angiotensinogen (Agt). (D) qChIP analysis of Flag-tagged Prdm16 in MSC-Ctl and 
Prdm16-Flag cell lines amplified with primers for the gene promoters of p107 (-214 to -
32) or positive control angiotensinogen (Agt) (-127 to +23) (n=3) All data are mean +/- 
SD. Note that Prdm16 interacts at the p107 promoter. 
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Figure 8. p107 is activated by nuclear translocation in G0/G1 (A) Representative 
Western blot of whole cell (W), cytoplasmic (C), and nuclear (N) fractions for p107, α-
Tubulin (cytoplasmic control) and Histone H3 (nuclear control) during proliferation (Pr), 
0hrs, 24 hours and 48 hours at confluency in Wt MEFs. (B) Representative Western blot 
of C and N fractions for p107, α-Tubulin and Histone H3 during Pr, 0hrs, 24 hours and 
48 hours in C3H10T1/2 (C) Histograms of MEFs and C3H10T1/2 cells stained with PI 
and analyzed by flow cytometry during Pr, 0hrs, 24 hours and 48 hours at confluency. 
The peak areas represent the cell population in G0/G1, S and G2/M. Note that when cells 
reach confluency they are in a G0/G1 state. 
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Figure 9. p107 KO MEFs have increased O2 consumption in G0/G1 and 
differentiation. (A) Diagram representing the consecutive addition of substrates to 
Oroboros Oxygraph-2K (B) State 3 respiration reflecting the capacities for oxidative 
phosphorylation supported by both NADH-generating complex I substrates glutamate 
and malate (GM3) and together with pyruvate (GMP3) and by FADH2-generating 
complex II substrates GMP with succinate (GMPS3); as well as proton leak assessed 
during non-ADP dependent respiration (State 2 respiration; complex 1 supported by 
GM before the addition of ADP) and in the presence of oligomycin (Oligo) after the 
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addition of ADP (both complex I and II supported by GMPS) of p107 KO and Wt MEFs 
during proliferation, G0/G1, and Day 3 and Day 7 of adipocyte differentiation. Note 
genetic deletion of p107 has no effect on mitochondrial oxygen consumption during 
proliferation (n=3-5, asterisks denote significance, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001). All data are mean +/- SD. 
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Figure 10. p107 depletion increases O2 consumption in G0/G1 and differentiation (A) 
Representative Western blot and graphical representation of p107 protein levels in 
C3H10T1/2, Ctl and p107 KD cell lines. (n=4, One-way ANOVA and Tukey Post-hoc 
test were used, different letters indicate significant difference p<0.0001). (B) State 3 
respiration reflecting the capacities for oxidative phosphorylation supported by both 
NADH-generating complex I substrates glutamate and malate (GM3) and together with 
pyruvate (GMP3) and by FADH2-generating complex II substrates GMP with succinate 
(GMPS3); as well as proton leak assessed during non-ADP dependent respiration (State 2 
respiration; complex 1 suppored by GM before the addition of ADP) and in the presence 
of oligomycin after the addition of ADP (both complex I and II supported by GMPS) of 
St
ate
 2
GM
3
GM
P 3
GM
PS
3
Ol
igo
0
10
20
30
40
50
O
2 c
on
su
m
pt
io
n
 (p
m
ol
/s
ec
/m
ill
io
n 
ce
lls
) Ctl
p107 KD
St
ate
 2
GM
3
GM
P 3
GM
PS
3
Ol
igo
0
10
20
30
40
O
2 c
on
su
m
pt
io
n
 (p
m
ol
/s
ec
/m
ill
io
n 
ce
lls
) Ctl
p107 KD
**
***
*
***
St
ate
 2
GM
3
GM
P 3
GM
PS
3
Ol
igo
0
50
100
150
O
2 c
on
su
m
pt
io
n
 (p
m
ol
/s
ec
/m
ill
io
n 
ce
lls
) Ctl
p107 KD
****
****
**
**
***
St
ate
 2
GM
3
GM
P 3
GM
PS
3
Ol
igo
0
50
100
150
200
250
O
2 c
on
su
m
pt
io
n
 (p
m
ol
/s
ec
/m
ill
io
n 
ce
lls
) Ctl
p107 KD
****
****
****
****
****
Proliferation G0/G1
Day 3 Day 7
Figure 10
B)
A)
C3H
10T1
/2 
Ctl p107
 KD 
p107 
αTubulin 
C3H10T1/2 Ctl p107 KD
0.0
0.5
1.0
1.5
2.0
Fo
ld
 C
ha
ng
e
p107
a
a
b
60	  	  
	   	  
Ctl and p107 KD cell lines during proliferation, G0/G1, and Day 3 and Day 7 of adipocyte 
differentiation. Note p107 depletion has no effect on mitochondrial oxygen consumption 
during growth. (n= 4-5, asterisks denote significance, *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001). All data are mean +/- SD. 
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Figure 11. p107-depleted stem cells have altered NADH partitioning in G0/G1 (A) 
Gene expression analysis by qPCR for markers of the Malate-Aspartate shuttle: cytosolic 
aspartate transaminase (Got1), Malate Dehydrogenase 1 (Mdh1), Malate-αKetoglutarate 
Antiporter (Mal-αKG Pore), Malate Dehydrogenase 2 (Mdh2), mitochondrial aspartate 
transaminase (Got2), and Glutamate-Aspartate Antiporter (Glu-Asp Pore), and in Wt and 
p107 KO MEFs during proliferation and G0/G1 (n=3-5, *p<0.05, **p<0.01).	   (B) Gene 
expression analysis by qPCR for markers of the Malate-Aspartate shuttle as in (A) in Ctl 
and p107 KD cell lines during proliferation and G0/G1 (n=3-4, *p<0.05, **p<0.01).	  All 
data are mean +/- SD. 
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Figure 12. p107-KO and KD stem cells participate in anaerobic glycolysis at G0/G1 
(A) Gene expression analysis by qPCR of lactate dehydrogenase (Ldha) in p107 KO and 
Wt MEFs during proliferation and G0/G1 (p<0.05). (B) Representative western blot and 
graphical representation of Ldha protein levels in p107 KO and Wt MEFs during 
proliferation and G0/G1 (p<0.001). (C) Gene expression analysis by qPCR of lactate 
dehydrogenase (Ldha) in Ctl and p107 KD cell lines during Pr and G0/G1 (p<0.01). (D) 
Representative western blot and graphical representation of Ldha protein levels in Ctl and 
p107 KD cell lines during proliferation and G0/G1 (p<0.01). (n=3-4, Two-way ANOVA 
and Tukey Post-hoc test were used, different letter indicates significant difference).  
All data are mean +/- SD. 
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Figure 13. p107-KO and KD stem cells participate in anaerobic glycolysis at G0/G1 
(A) Gene expression analysis by qPCR of pyruvate dehydrogenase (Pdk2) in p107 KO 
and Wt MEFs during proliferation and G0/G1 (p<0.05). (B) Representative western blot 
and graphical representation of Pdk2 protein levels in p107 KO and Wt MEFs during 
proliferation and G0/G1 (p<0.001). (C) Gene expression analysis by qPCR of pyruvate 
dehydrogenase (Pdk2) in Ctl and p107 KD cell lines during Pr and G0/G1 (p<0.05). (D) 
Representative western blot and graphical representation of Pdk2 protein levels in Ctl and 
p107 KD cell lines during proliferation and G0/G1 (p<0.01). (n=3-4, Two-way ANOVA 
and Tukey Post-hoc test were used, different letter indicates significant difference. All 
data are mean +/- SD. 
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Figure 14. p107 KD cells have enhanced β-oxidation in G0/G1 (A) Diagram 
representing the protocol of consecutive addition of substrates to measure fatty acid β-
oxidation potential. (B) Substrates were added consecutively according to (A) and total 
O2 consumption was measured in Ctl and p107 KD cell lines during proliferation and 
G0/G1 states (n=4, Two-way ANOVA and Tukey Post-hoc test were used, different letter 
indicates significant difference, p<0.05). (C) Gene expression analysis by qPCR for 
markers of fatty acid transport: Fatty acid transport protein 4 (Fatp4), Carnitine 
palmitoyltransferase 1b (Cpt1b), Carnitine palmitoyltransferase 1c (Cpt1c), Carnitine-
acylcarnitine translocase (Cat) and Carnitine palmitoyltransferase 2 (Cpt2), in Ctl and 
p107 KD cell lines during proliferation and G0/G1 (n=3, *p<0.05). 
All data are mean +/- SD. 
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Figure 15. Anaerobic glycolysis in G0/G1 is necessary for brown-type differentiation  
(A) Oil Red O staining after 7 days of adipocyte differentiation of Ctl and p107 KD cells 
treated with DMSO or oxamate. (B) Gene expression analysis by qPCR of Ucp1 after 7 
days post differentiation in Ctl and p107 KD cells treated with DMSO or oxamate (n=4-
5, Two-way ANOVA and Tukey Post-hoc test were used, different letter indicates 
significant difference, p<0.05. All data are mean +/- SD. Note that inhibition of 
anaerobic glycolysis via oxamate administration prevented the brown-type differentiation 
potential of p107 KD stem cells.   
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Figure 16. Metabolic reprogramming in the presence or absence of p107. See text for 
further details.    
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